Showing grants tagged "Global Health R&D"

We’re open to supporting safe bets, like direct cash transfers to the world’s poorest people, as well as high-risk, high-reward projects, like minimizing risks from potentially world-changing science and technology. Read more about how we choose what to fund here.

Topics

Click a topic below to filter results for this section.

  1. Swiss Tropical and Public Health Institute – Emodepside Phase III Trial

    Award Date:
    04/2024
    Amount:
    $5,000,000
    Global Health R&D

  2. International AIDS Vaccine Initiative – Samples for Tuberculosis Vaccine Trial

    Award Date:
    03/2024
    Amount:
    $796,878
    Global Health R&D

  3. Malaria Research and Training Center – TB31F Clinical Trial

    Award Date:
    03/2024
    Amount:
    $2,320,803
    Global Health R&D

  4. University of Oxford — Monoclonal Antibody Development for Malaria

    Award Date:
    11/2023
    Amount:
    $300,000
    Global Health R&D

  5. Clinton Health Access Initiative — Tuberculosis Drug Price Reduction

    Award Date:
    11/2023
    Amount:
    $600,000
    Global Health R&D

  6. Molecular Approaches to Malaria Conference — General Conference Support and Travel Grants

    Award Date:
    10/2023
    Amount:
    $60,000
    Global Health R&D

  7. Clinton Health Access Initiative — Scoping Grant for Sickle Cell Disease Market Shaping

    Award Date:
    10/2023
    Amount:
    $204,332
    Global Health R&D

  8. The International Union Against Tuberculosis and Lung Disease — Conference Scholarships

    Award Date:
    10/2023
    Amount:
    $50,000
    Global Health R&D

  9. Obafemi Awolowo University — Atorvastatin Combination Trial for Tuberculosis

    Award Date:
    09/2023
    Amount:
    $318,450
    Global Health R&D

  10. Cures Within Reach — Generic Drug Trials

    Award Date:
    05/2023
    Amount:
    $800,000
    Global Health R&D